Cargando…
Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
Major depressive disorder (MDD) is a common disorder involving depressive mood and decreased motivation. Due to its high heterogeneity, novel biomarkers are required to diagnose MDD. In this study, a proteomic method was used to identify a new MDD biomarker. Using sequential window acquisition of al...
Autores principales: | Choi, Hyebin, Mun, Sora, Joo, Eun-Jeong, Lee, Kyu Young, Kang, Hee-Gyoo, Lee, Jiyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002827/ https://www.ncbi.nlm.nih.gov/pubmed/33802981 http://dx.doi.org/10.3390/diagnostics11030539 |
Ejemplares similares
-
Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
por: Lee, Seungyeon, et al.
Publicado: (2022) -
Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses
por: Lee, Jiyeong, et al.
Publicado: (2015) -
Biomarker Discovery of Acute Coronary Syndrome Using Proteomic Approach
por: Shin, Miji, et al.
Publicado: (2021) -
Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach
por: Shin, Miji, et al.
Publicado: (2021) -
Proteomics-Based Identification of Diagnostic Biomarkers Related to Risk Factors and Pathogenesis of Ischemic Stroke
por: Lee, Jiyeong, et al.
Publicado: (2020)